Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2007
11/21/2007CN101074439A Protein-nucleic acid block, its production and use
11/21/2007CN101074327A Improved yellow iron oxide pigment
11/21/2007CN101074325A Effect pigments based on coated glass flakes
11/21/2007CN101074249A Aminoglycoside antibiotics derivative
11/21/2007CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues
11/21/2007CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007CN101073615A Production of drop-pill preparation in treatment of pelvic inflammatory disease
11/21/2007CN101073591A Medicinal composition for treating cardiovascular and cerebrovascular diseases
11/21/2007CN101073573A Oral beta-lactam antibiotic slow-release composition
11/21/2007CN101073572A Medicinal composition for treating cold wet numbness and its production
11/21/2007CN101073567A Butylbenzene phthalein concentrated solution for injection and its making method
11/21/2007CN101073566A Production and use for tanshinone component injection
11/21/2007CN101073562A Instant taurine eyes gel
11/21/2007CN101073560A Production of release-controlled film in percutaneous medicine-feeding system
11/21/2007CN101073558A Bio-degradable contraceptive micropill and its production
11/21/2007CN101073556A Eyes preparation for divergent pupil and its making method
11/21/2007CN101073555A Injecting tanshinone II and its derivative concentrated solution and its production
11/21/2007CN101073554A Anti-cancer composition containing tyrosine kinase inhibitor and alkylating agent
11/21/2007CN101073553A Cromolyn-sodium eyes gel
11/21/2007CN101073537A Fine emulsion of oil in water
11/21/2007CN101073386A Malt-sugar alcohol grain for direct tabletting and its production
11/21/2007CN100349963C Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles
11/21/2007CN100349938C Cross-linked polymer, polymer fine particle and method for producing them
11/21/2007CN100349632C Microprojection array having beneficial agent contg coating
11/21/2007CN100349627C Medical devices containing rapamycin analogs
11/21/2007CN100349614C Solid mixture containing alpha-amylase and its prepn process and application in pharmaceutical industry
11/21/2007CN100349613C Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
11/21/2007CN100349612C Sustained releasing microspheric preparation of glucokinase mutant and its making method
11/21/2007CN100349573C Formulation for lipophilic agents
11/21/2007CN100349571C Transdermal therapeutic system containing testosterone and method for the production thereof
11/21/2007CN100349567C (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application
11/21/2007CN100349562C Ophthalmic drug delivery device
11/20/2007US7297794 Phenoxy amine compounds and compositions for delivering active agents
11/20/2007US7297784 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
11/20/2007US7297775 Polypeptide variants
11/20/2007US7297759 Peptides for increasing transfection efficiency
11/20/2007US7297716 Enhanced production of blood components, blood cells and plasma without freezing
11/20/2007US7297712 Coupling an aliphatic bromide with an aliphatic alkylamine, protecting both terminal primary alcohol groups of aliphatic alcohol, reacting both intermediates, quaternizing the product, passing quaternized product through a chroamtograph
11/20/2007US7297703 Macrolides
11/20/2007US7297676 Thymosin alpha 1 peptide/polymer conjugates
11/20/2007US7297348 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
11/20/2007US7297346 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain attention deficit hyperactivity disorder and fatigue
11/20/2007US7297335 Immunotoxins directed against CD33 related surface antigens
11/20/2007US7297328 Surfactant-free cosmetic, dermatological and pharmaceutical agents
11/20/2007CA2405205C Method for preparing microspheres
11/20/2007CA2398906C Sterile water generator
11/20/2007CA2378265C Solid preparations containing chitosan powder and process for producing the same
11/20/2007CA2341410C Hydrogel compositions for the controlled release administration of growth factors
11/20/2007CA2316841C Crystallographically stable amorphous cephalosporin compositions and process for producing the same
11/20/2007CA2268600C Topical dmso treatment for palmar-plantar erythrodysesthesia
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/20/2007CA2254144C Pharmaceutical compositions based on diclofenac
11/20/2007CA2234615C Sustained release particles
11/20/2007CA2216372C Oral 2-methyl-thieno-benzodiazepine formulation
11/20/2007CA2214436C Corticosteroid-containing pharmaceutical composition
11/20/2007CA2211389C Novel pharmaceutical combination
11/20/2007CA2200746C Injection-molded dosage form
11/20/2007CA2186126C Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
11/16/2007CA2554386A1 Combinations of hmg coa reductase inhibitors and negatively charged phospholipids and uses thereof
11/15/2007WO2007130848A2 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
11/15/2007WO2007129712A1 Transdermally absorbable donepezil preparation
11/15/2007WO2007129706A1 Edible film package having product for oral intake enclosed therein
11/15/2007WO2007129329A2 Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
11/15/2007WO2007128923A2 Method for the preparation of a biocompatible gel with controlled release of one or more active ingredients with low solubility in water, gels thus obtained and their use
11/15/2007WO2007128815A1 Insulin derivative
11/15/2007WO2007128550A1 Biocompatible three dimensional matrix for the immobilization of biological substances
11/15/2007WO2007128476A1 Pharmaceutical compositions containing clopidogrel hydrochloride
11/15/2007WO2007128107A1 Modified release tablets comprising tramadol
11/15/2007WO2007110001A3 Chimeric proteins comprising matrilin 1 for therapeutic use
11/15/2007WO2007107679A3 Association of oleaginous substance with a mixture of at least two cyclodextrins
11/15/2007WO2007100829A3 Method for making polyethylene glycol carbonates
11/15/2007WO2007093617A3 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
11/15/2007WO2007084693A3 Immunoconjugates with improved efficacy for the treatment of diseases
11/15/2007WO2007084692A3 Immunoconjugates for treatment of infectious diseases
11/15/2007WO2007067682A3 In vivo cell surface engineering
11/15/2007WO2007066150A3 Transdermal administration of active agents for systemic effect
11/15/2007WO2007048121A3 Methods of preparing targeted immunoliposomes
11/15/2007WO2007043057A3 Compositions for nasal delivery
11/15/2007WO2006119498A3 Pharmaceutical compositions with synchronized solubilizer release
11/15/2007WO2006100075A8 Use of an artificial sweetener to enhance absorption of nicotine
11/15/2007WO2006089537A8 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
11/15/2007WO2006039704A3 Pharmaceutical composition and method for treating a joint capsule arthropathy
11/15/2007WO2005118702A3 Unagglomerated core/shell nanocomposite particles
11/15/2007WO2005092369A3 Conjugates of hydroxyethyl starch and erythropoietin
11/15/2007WO2005046572A3 Targeted delivery of controlled release polymer systems
11/15/2007WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007WO2002019842A3 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
11/15/2007US20070265436 Nucleotide sequences coding tumor-associated antigenic target polypeptide specific immunoglobulins for use in detection and prevention of cell proliferative disorders
11/15/2007US20070265434 Simplified method to retrieve chitosan from acidic solutions thereof
11/15/2007US20070265355 Polyketal polymers, and methods of making and using same
11/15/2007US20070265349 Medicinal association of a biguanine and a carrier, for example metformin and arginine
11/15/2007US20070265334 Method for treating amyloidosis
11/15/2007US20070265234 Methods for stabilizing oxidatively unstable compositions
11/15/2007US20070265212 Drug Transport and Delivery System
11/15/2007US20070265194 Agents for the treatment of viral infections
11/15/2007US20070265192 Telechelic Homopolyamino Acids Functionalized with Hydrophobic Groups, and Their Applications, Especially Therapeutic Applications
11/15/2007US20070265186 Biotin-Facilitated Transport in Gram Negative Bacteria
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264345 liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, 26.7-40.0%, propylene-glycol, 13.3-20.0%, isopropyl myristate, 5.0-35.0%, ethanol, 0.01-10.0%, benzyl alcohol, 0.5-1.5%, a hyaluronic acid salt or complex 0.01-2.00%, and purified water, 12.5-26.5%; healing cosmetics
11/15/2007US20070264344 Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
1 ... 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 ... 1712